To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Paul Capital Healthcare does $100m pharma deal
Pharmaceutical companies are looking to alternative forms of financing for research and marketing in the market downturn, according to Paul Capital partner Ken Macleod.
